Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment of borrowings
Repaying or prepaying, in full or in part, certain outstanding borrowings of the company and of its subsidiary, which reduces interest cost and frees up the balance sheet.
General corporate purposes
The balance of the net proceeds of the fresh issue, after the debt repayment and the expenses of the issue, is reserved for general corporate purposes at the discretion of the board.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Gem Aromatics Limited is a Mumbai based manufacturer of speciality ingredients used by the flavour and fragrance industry. Incorporated in October 1997, it makes essential oils, aroma chemicals and the value added derivatives built from them, taking raw botanical inputs through to refined compounds. Its catalogue runs to roughly 70 products grouped into four families: mint and its analogues, clove and its analogues, phenol, and a mix of other natural and synthetic substances. The company sells into oral care, cosmetics, nutraceuticals and pharmaceuticals, supplying both Indian consumer goods makers and overseas buyers. Its customer list has included large household names in personal care, and it serves roughly 170 domestic customers alongside about 30 international ones spread across some 13 countries in the Americas, Asia, Africa and Australia. Product development is handled in house by a research team of around 15 scientists, which lets it tailor derivatives to a customer's specification rather than selling only standard grades. Revenue grew from about Rs 425 crore in FY2023 to roughly Rs 506 crore in FY2025, with profit after tax rising from about Rs 45 crore to about Rs 53 crore over the same three years. The business is concentrated in mint chemistry, which accounts for the bulk of sales, so its economics track the price and availability of mint and clove feedstock closely. Growth depends on pushing further into higher value derivatives and on deepening relationships with the large consumer goods customers that buy in volume.
The company raised about Rs 135.37 crore from anchor investors on 18 August 2025, the day before the issue opened, allotting 41,65,383 shares at the upper band price of Rs 325 each, which is 60 percent of the QIB portion. Thirteen institutions took part, among them Citigroup Global, Goldman Sachs, Societe Generale, Nippon India Mutual Fund, SageOne, Nuvama and the Niveshaay Sambhav Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 13 July 2026, 5:30 AM
Broad derivative range across four product families
The company makes around 70 products spanning mint, clove, phenol and other natural and synthetic compounds, and it moves customers up from basic ingredients into higher value derivatives. That breadth lets it serve several end industries from one plant base.
Long standing consumer goods customers
It supplies large oral care and personal care manufacturers that buy in volume and qualify their suppliers slowly. Once a compound is designed into a customer's formulation, the relationship tends to persist.
In house research capability
A team of roughly 15 scientists develops products to customer specification rather than selling only off the shelf grades, which supports pricing and makes the company harder to substitute.
Export reach across thirteen countries
Around 30 international customers across the Americas, Asia, Africa and Australia sit alongside the domestic book, so demand is not tied to a single market's cycle.
Steady revenue and profit growth
Revenue and profit after tax both rose in each of the three reported financial years, and margins held up rather than being given away to win the volume.
Heavy dependence on mint chemistry
Mint and its derivatives account for the large majority of revenue. A shift in mint feedstock prices, a poor crop, or a customer moving to a synthetic substitute would hit the bulk of the business at once.
Customer concentration
A meaningful slice of sales comes from a handful of large buyers. Losing one of them, or a change in their sourcing strategy, would leave a visible gap that is hard to refill quickly.
No long term contracts
The company does not hold firm long term agreements with its key customers or its suppliers, so volumes and input costs are both renegotiated repeatedly rather than locked in.
Gem Aromatics Limited
A/410, Kailas Complex, Vikhroli Powai Link Road, Park Site, Vikhroli (W), Mumbai, Maharashtra 400079
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Raw material price volatility
Botanical feedstock prices move with harvests and weather. Because the company buys inputs before it sells the finished derivative, a sharp move in either direction compresses margins.
Litigation over the Budaun land
There is an unresolved legal dispute concerning land at the company's Budaun facility. An adverse outcome could affect operations at that site.
Rising borrowings
Total borrowing roughly doubled in FY2025 as the company invested in the business. A chunk of the fresh issue goes to paying debt down, but the leverage bears watching.